KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Other Non Operating Income: 2016-2024

Historic Other Non Operating Income for Moderna (MRNA) over the last 9 years, with Dec 2024 value amounting to -$87.0 million.

  • Moderna's Other Non Operating Income rose 129.63% to $8.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was -$37.0 million, marking a year-over-year increase of 72.79%. This contributed to the annual value of -$87.0 million for FY2024, which is 29.84% up from last year.
  • Latest data reveals that Moderna reported Other Non Operating Income of -$87.0 million as of FY2024, which was up 29.84% from -$124.0 million recorded in FY2023.
  • Moderna's Other Non Operating Income's 5-year high stood at -$6.0 million during FY2020, with a 5-year trough of -$124.0 million in FY2023.
  • In the last 3 years, Moderna's Other Non Operating Income had a median value of -$87.0 million in 2024 and averaged -$85.3 million.
  • Per our database at Business Quant, Moderna's Other Non Operating Income slumped by 383.33% in 2021 and then rose by 29.84% in 2024.
  • Over the past 5 years, Moderna's Other Non Operating Income (Yearly) stood at -$6.0 million in 2020, then slumped by 383.33% to -$29.0 million in 2021, then crashed by 55.17% to -$45.0 million in 2022, then tumbled by 175.56% to -$124.0 million in 2023, then rose by 29.84% to -$87.0 million in 2024.